Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 28, 2014; 20(40): 14927-14933
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14927
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14927
Table 2 Post-operative complications in the trial group and the control group
| Complication | Trial group | Control group | P-value |
| Pancreatic fistula | 2 | 3 | 0.484 |
| Stoma fistula | 1 | 0 | 0.508 |
| Peritoneal effusion or abscess | 1 | 6 | 0.046 |
| Bowel obstruction | 0 | 1 | 0.492 |
| Pneumonia | 2 | 0 | 0.256 |
| Chylous fistula | 3 | 3 | 0.644 |
| Incision infection or dehiscence | 2 | 1 | 0.513 |
| Post-operative pancreatitis | 1 | 2 | 0.487 |
| Total | 14 | 17 | 0.463 |
- Citation: Song W, Chen JH, Zhang XH, Xu JB, He YL, Cai SR, Han FH, Chen CQ. Effect of somatostatin in advanced gastric cancer after D2 radical gastrectomy. World J Gastroenterol 2014; 20(40): 14927-14933
- URL: https://www.wjgnet.com/1007-9327/full/v20/i40/14927.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i40.14927